Did Recent Court Rulings Force the FDA to Delay Approving Pfizer’s COVID Shots for Infants?
Operation Warp Speed has hit its first bump in the road. The U.S. Food and Drug Administration (FDA) announced yesterday that it was delaying approval of Pfizer's COVID-19 vaccines for young children between the ages of 6 months and 4 years old. Since up until this point the FDA has illegally approved all other Pfizer COVID-19 "vaccines" by simply rubber-stamping Pfizer's own data which is hidden from the public, the question that begs to be answered is, why? Pfizer has worked hard to hide the clinical data from their trials from the public, but recent court rulings have not exactly gone their way. The FDA had originally asked the court to delay releasing their clinical data for 75 years, but then agreed to provide 500 pages per month. In late January, Attorney Aaron Siri reported that a federal judge shot down the FDA’s requested rate of 500 pages per month and instead ordered the FDA to produce at the rate of 55,000 pages per month starting on March 1. Siri also reported that Pfizer was joining the FDA in the case. And why not, since the FDA basically works for Pfizer? Last week, the judge in this case, U.S. District Judge Mark Pittman, denied Pfizer's request (for now) to join the case. The next day, Pfizer redlined changes in their 4th quarter earnings release from 2021, adding language warnings that 'Unfavorable Pre-Clinical, Clinical Or Safety Data' may impact business in 2022. It's too bad for Pfizer that Donald Trump is no longer president, because he could have intervened to help Pfizer get their shots out to those 18 million children by strong-arming the FDA, like he originally did back in December 2020 when he threatened the FDA head, Dr. Stephen Hahn, to approve the COVID-19 shots or be fired.